S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

Trimedyne Stock Forecast, Price & News

0.00 (0.00%)
(As of 03/20/2020)
Today's Range
50-Day Range
52-Week Range
110 shs
Average Volume
570 shs
Market Capitalization
$522.75 thousand
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive TMED News and Ratings via Email

Sign-up to receive the latest news and ratings for Trimedyne and its competitors with MarketBeat's FREE daily newsletter.

Trimedyne logo

About Trimedyne

Trimedyne, Inc. manufactures and sells lasers, and disposable and reusable fiber-optic laser devices for use in the medical field. It offers lasers, fibers, needles, and switch tips for use in orthopedics, urology, ear and nose surgery, throat surgery, gynecology, gastrointestinal surgery, general surgery, and other medical specialties. The company also provides 80 watt and 30 watt holmium lasers, and side firing laser needles to treat herniated or ruptured spinal discs. In addition, it engages in the provision of services, and rental of lasers and other medical equipment to hospitals and surgery centers on a fee-per-case basis. The company operates in Asia, Europe, Latin America, the Middle East, Australia, and internationally. It markets its products through commission sales representatives in the United States and independent distributors internationally. Trimedyne, Inc. was founded in 1980 and is based in Irvine, California.


See More Headlines

Industry, Sector and Symbol

Electromedical equipment
Current Symbol
Year Founded

Sales & Book Value

Annual Sales


Pretax Margin




Free Float
Market Cap
$522.75 thousand
Not Optionable

Company Calendar

Last Earnings
Fiscal Year End


Overall MarketRank

0.94 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -

Trimedyne (OTCMKTS:TMED) Frequently Asked Questions

How has Trimedyne's stock price been impacted by COVID-19 (Coronavirus)?

Trimedyne's stock was trading at $4.30 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, TMED stock has decreased by 1.2% and is now trading at $4.25.
View which stocks have been most impacted by COVID-19

How were Trimedyne's earnings last quarter?

Trimedyne, Inc. (OTCMKTS:TMED) announced its earnings results on Tuesday, February, 20th. The technology company reported $0.70 earnings per share for the quarter. The technology company earned $1.53 million during the quarter.
View Trimedyne's earnings history

Who are Trimedyne's key executives?

Trimedyne's management team includes the following people:
  • Mr. Glenn D. Yeik, Interim Chairman, CEO & Pres (Age 51)
  • Mr. Brian T. Kenney, VP of Global Sales & Marketing (Age 62)

What other stocks do shareholders of Trimedyne own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trimedyne investors own include Aflac (AFL), Diana Shipping (DSX), Cohen & Steers Closed-End Opportunity Fund (FOF), Incyte (INCY), National Fuel Gas (NFG), PDC Energy (PDCE), The Rank Group (RNK), Safehold (SAFE), Snap (SNAP) and Aramark (ARMK).

What is Trimedyne's stock symbol?

Trimedyne trades on the OTCMKTS under the ticker symbol "TMED."

How do I buy shares of Trimedyne?

Shares of TMED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Trimedyne's stock price today?

One share of TMED stock can currently be purchased for approximately $4.25.

How much money does Trimedyne make?

Trimedyne has a market capitalization of $522.75 thousand.

What is Trimedyne's official website?

The official website for Trimedyne is www.trimedyne.com.

Where are Trimedyne's headquarters?

Trimedyne is headquartered at 5 HOLLAND BLDG #223, IRVINE CA, 92618.

How can I contact Trimedyne?

Trimedyne's mailing address is 5 HOLLAND BLDG #223, IRVINE CA, 92618. The technology company can be reached via phone at 949-951-3800 or via fax at 949-855-8206.

This page was last updated on 11/27/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.